First successful pregnancy outcome after preimplantation genetic diagnosis for aneuploidy screening in embryos generated from natural-cycle in vitro fertilization combined with an in vitro maturation procedure

2006 ◽  
Vol 85 (5) ◽  
pp. 1510.e9-1510.e11 ◽  
Author(s):  
Asangla Ao ◽  
Shaoguang Jin ◽  
Durga Rao ◽  
Weon-Young Son ◽  
Ri-Cheng Chian ◽  
...  
Author(s):  
N.A. Altinnik , S.S. Zenin , V.V. Komarova et all ,

Сurrent problems and prerequisites for the formation of the legal regime of pre-implantation genetic diagnosis (PGD) are considered in Russian legislation with account the existing approaches to determining the legal status of a “pre-implantation” embryo obtained in the framework of the in vitro fertilization procedure (IVF) are discussed. The authors substantiates the conclusion that it is necessary to legally determine PGD as one of the stages of using IVF, as well as establishing generally binding requirements for the procedure, conditions and features of this diagnosis, taking into account the need to minimize the damage caused to the human embryo.


2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Shital Julania ◽  
Melanie L. Walls ◽  
Roger Hart

In vitro maturation (IVM) of human oocytes is an emerging treatment option for women with polycystic ovary/polycystic ovary syndrome (PCO/PCOS) in addition to the standard in vitro fertilization (IVF) treatment. There has been significant improvements in pregnancy rates with IVM over the last two decades. This article reviews the place of IVM for women with PCO/PCOS, placing an emphasis on the predictors of successful pregnancy, optimization of culture media, IVM protocols, pregnancy rates, and neonatal outcomes following IVM treatment.


2004 ◽  
Vol 81 (5) ◽  
pp. 1302-1307 ◽  
Author(s):  
Martin Wilding ◽  
Robert Forman ◽  
George Hogewind ◽  
Loredana Di Matteo ◽  
Fulvio Zullo ◽  
...  

Author(s):  
Inmaculada de Melo-Martín

This chapter offers a brief description of the main reprogenetic technologies in use today as well as some of the most significant ones being developed. Because of their relevance in the field, particular attention is given to in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD). The chapter discusses the differences between somatic and germline modifications, the most common uses of reprogenetic technologies today, and some possible and likely future uses. It also includes a description of recent technological advances such as mitochondrial transfer and gene editing techniques.


Sign in / Sign up

Export Citation Format

Share Document